Bristol-Myers Squibb Company (1BMY)
MTA
Closed
Oct 2, 2026
Day's Range
54.0452 wk Range
36.67Overview - 1BMY - Bristol-Myers Squibb Company
Key Statistics
Valuation
Enterprise Value
125.92B
P/E (Trailing)
‪13.52‬
PEG Ratio
‪0.08‬
Price / Sales (TTM)
‪2.22‬
Price / Book
‪5.61‬
EV / EBITDA
‪7.59‬
Profitability
Gross Margin
‪71.27%‬
Profit Margin
‪18.87%‬
Operating Margin
‪34.41%‬
Return on Assets
‪10.71%‬
Return on Equity
‪46.59%‬
Ownership
Shares Outstanding
2.04B
Float
2.03B
Held by Insiders
‪0.09%‬
Held by Institutions
‪84.87%‬
Price stats
Beta
‪0.22‬
50-Day Avg
‪55.93‬
200-Day Avg
‪50.98‬
Dividends
Payout Ratio
‪55.29%‬
Frequency
Quarterly
Market Cap - 1BMY - Bristol-Myers Squibb Company
Peers - 1BMY - Bristol-Myers Squibb Company
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on MTA.
- 1BMYMTABristol-Myers Squibb Company99.09BMarket Cap+30.15%52-week change13.53P/E (Trailing)‪18.87%‬Profit Margin
- 1LLYMTAEli Lilly and Company853.56BMarket Cap+39.59%52-week change39.07P/E (Trailing)‪33.52%‬Profit Margin
- 1JNJMTAJohnson & Johnson428.46BMarket Cap+35.10%52-week change31.33P/E (Trailing)‪21.48%‬Profit Margin
- 1ABBVMTAAbbVie Inc.344.57BMarket Cap+18.25%52-week change74.58P/E (Trailing)‪9.80%‬Profit Margin
- 1ROMTARoche Holding AG294.63BMarket Cap+26.64%52-week change24.41P/E (Trailing)‪19.60%‬Profit Margin
- 1MRKXMTAMerck & Co., Inc.240.41BMarket Cap+48.40%52-week change117.34P/E (Trailing)‪4.76%‬Profit Margin
- 1NOVNMTANovartis AG Registered Shares238.75BMarket Cap+17.17%52-week change21.78P/E (Trailing)‪22.50%‬Profit Margin
Profile Summary - 1BMY - Bristol-Myers Squibb Company
About
Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures, and commercializes medicines for serious diseases. Bristol-Myers Squibb Company focuses on major therapeutic areas including oncology, hematology, immunology, cardiovascular disease, and neuroscience, serving…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
